The pharmaceutical giant Novartis is cutting up to 500 jobs at its Basel headquarters and pharmaceuticals division as part of a restructuring plan, a move that could include layoffs. The company said the job reductions were necessary to guarantee the ‘necessary resources’ for the launch of products this year.
English: http://www.thelocal.ch/20140121/novartis-lops-500-pharma-jobs-in-basel
For more information, please contact the editor Jan Cremers, Amsterdam Institute for Advanced Labour Studies (AIAS) cbn-aias@uva.nl or the communications officer at the ETUI, Mariya Nikolova mnikolova@etui.org. For previous issues of the Collective bargaining newsletter please visit http://www.etui.org/E-Newsletters/Collective-bargaining-newsletter. You may find further information on the ETUI at www.etui.org, and on the AIAS at www.uva-aias.net.